medigraphic.com
ISSN 1405-8871 (Print)

2022, Number 4

<< Back Next >>

Aten Fam 2022; 29 (4)

Management of Patients with Medically Unexplained Physical Symptoms (MUS). Part I

Ramírez-Aranda JM, Martínez-Gutiérrez CM, Terviño-Uresti YK, Escobedo-Gil JM

Language: Spanish
References: 21
Page: 263-267
PDF size: 169.03 Kb.


ABSTRACT

Patients with “medically unexplained physical symptoms” (MUS) are frequent in the medical office; these patients go for consultation due to nonspecific symptoms, of uncertain etiology, without a defined clinical picture, normal physical examination for their complaint, and laboratory and imaging without abnormalities. The approach to a patient with MUS can be a challenge, causing frustration in the physician and dissatisfaction in the patients; it implies higher costs of care and saturation of health services. There are several nonpharmacological interventions that have shown to be useful. The family physician must acquire certain skills to care for these patients. In this review, the stages are orderly described for the approach to mus patients, such as:
1. What to do? Work on symptom reattribution. Establish connection: between stressful event and non-specific symptom(s). 2. How to do it? Implement an approach guide: perceptual and executive skills of the professional treating. 3. When to do it? (timing). Training in symptom reattribution practice; insight; mindfulness. It is essential that patients understand how psychological problems produce somatic symptoms, it should be assessed if the patient is ready to admit it and work on their source of stress or stressful event, also the patient’s family should be assessed.


REFERENCES

  1. Malterud K, Aamland A. Medically UnexplainedSymptoms: are we making progress? Br J GenPract. 2019;69(681):164-5.

  2. Kirmayer LJ, Groleau D, Looper KJ, Dao MD.Explaining medically unexplained symptoms. CanJ Psychiatry. 2004;49(10):663-72.

  3. Marks EM, Hunter MS. Medically UnexplainedSymptoms: an acceptable term? Br J Pain.2015;9(2):109-14.

  4. Burton C, Fink P, Henningsen P, Löwe B, Rief W,EURONET-SOMA Group. Functional somaticdisorders: discussion paper for a new commonclassification for research and clinical use. BMCMed. 2020;18(1):34.

  5. Lennox GAK, Kendall R. Interventions for medicallyunexplained symptoms in the emergency department:a critical literature review: A critical literaturereview. Eur J Emerg Med. 2020;27(2):94-8.

  6. Johnson, S. K. (2008). Medically unexplainedillness: Gender and biopsychosocial implications.Washington, DC, US: American Psychological Association.DOI: 10.1037/11623-000

  7. Lamahewa K, Buszewicz M, Walters K, Marston L,Nazareth I. Persistent unexplained physical symptoms:a prospective longitudinal cohort study inUK primary care. Br J Gen Pract. 2019;69(681):e246-53.

  8. Smith RC, Dwamena FC. Classification anddiagnosis of patients with medically unexplainedsymptoms. J Gen Intern Med. 2007;22(5):685-91.

  9. Kocalevent R-D, Hinz A, Brähler E. Standardizationof a screening instrument (PHQ-15) for somatizationsyndromes in the general population.BMC Psychiatry. 2013;13:91.

  10. Zonneveld LN, Sprangers MA, Kooiman CG, van’tSpijker A, Busschbach JJ. Patients with unexplainedphysical symptoms have poorer quality of life andhigher costs than other patient groups: a crosssectionalstudy on burden. BMC Health Serv Res.2013;13:520.

  11. Rodríguez González AM, Ramírez Aranda JM, deLos Santos Reséndiz H, Lara Duarte MY, PazaránZanella SO, Méndez López JF, et al. Health careutilization of Mexican patients with medically unexplainedphysical symptoms. Colomb Med (Cali).2016;47(3):155-159.

  12. Wortman MSH, Lokkerbol J, van der WoudenJC, Visser B, van der Horst HE, Olde HartmanTC. Cost-effectiveness of interventions for medicallyunexplained symptoms: A systematic review.PLoS One. 2018 Oct 15;13(10): e0205278. DOI:10.1371/journal.pone.0205278

  13. Husain M, Chalder T. Medically unexplainedsymptoms: assessment and management. Clin Med.2021;21(1):13-8.

  14. Martinez-Gutierrez CM, Hernandez-Garcia S,Vallejo-Solis M. Síndrome de intestino irritable,presentación de un caso y manejo por medicinafamiliar. Rev Mex med fam. DOI: 10.24875/rmf.20000077

  15. Christopher F Dowrick, Adele Ring, Gerry MHumphris, Peter Salmon. Normalisation of unexplainedsymptoms by general practitioners: a functionaltypology. Br J Gen Pract. 2004;54(500):165-70.

  16. Gutiérrez-Herrera RF, Ordóñez-Azuara Y, Gómez-Gómez C, Ramírez-Aranda JM, Méndez-EspinozaE, Martínez-Lazcano F. Análisis sobre elementos decontenido en medicina familiar para la identidadprofesional del médico familiar. Rev Méd la Paz.2019;25(1):58-67.

  17. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating theseverity of somatic symptoms. Psychosom Med.2002;64(2):258-266.

  18. Zijlema WL, Stolk RP, Löwe B, Rief W, BioSHaRE,White PD, et al. How to assess commonsomatic symptoms in large-scale studies: a systematicreview of questionnaires. J Psychosom Res.2013;74(6):459-68.

  19. Escobar JI, Cook B, Chen C, A Gara M, Alegría M,Interian A, Díaz E. Whether medically unexplainedor not, three or more concurrent somatic symptomspredict psychopathology and service use in communitypopulations. J Psychosom Res. 2010;69(1):1-8.

  20. Ramírez-Aranda JM, Morales-Ramírez M, Frías-Gómez VL, Gómez-Mez MV , del Castillo-GuzmánO, López-Mata CD. Atribución de síntomasen pacientes con Síntomas Médicamente No Explicados:un estudio de validación y desarrollo de laescala. Gaceta Médica de México. 2022;158(1):17-23.

  21. Stewart M, Brown JB, Weston WW, McWhinneyIR, McWilliam CL, Freeman TR. Patient-centredmedicine transforming the clinical method. ThousandOaks: Sage Publications; 1995.




2020     |     www.medigraphic.com